Skip to content

Impact of comorbidities on the outcome of allogeneic hematopoietic stem cell transplantation

Impact of comorbidities on the outcome of allogeneic hematopoietic stem cell transplantation - comorbidities on allo HCT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000000851
Enrollment
600
Registered
2007-11-01
Start date
2007-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematologic diseases

Interventions

None listed

Sponsors

KSGCT
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: all patients who receive HCT for the first time

Exclusion criteria

Exclusion criteria: patients who receive second HCT

Design outcomes

Primary

MeasureTime frame
non-relapse mortality and overall survival

Countries

Japan

Contacts

Public ContactAya Nakaya

Keio University School of Medicine Division of Hematology

nakaya1016@yahoo.co.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026